LCAR-M23 cells
BM2L201906
Phase 1 mab terminated
Quick answer
LCAR-M23 cells for Epithelial Ovarian Cancer is a Phase 1 program (mab) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Legend Biotech Corp
- Indication
- Epithelial Ovarian Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated